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1. First and foremost, are there any key leadership messages you want to get out to our 
readership? 
In my experience, during such emergency situations, the role of leadership concentrates 
primarily in facilitating the flow of clear and unambiguous information; to be able to 
identify which information is critical, identify the direction of travel and then enable 
the flow of additional information as needs arise. This pandemic is asynchronous, in 
other words it's not happening all over the world all at the same time, and some 
colleagues experience it earlier, and some much later. The leadership challenge lies in 
distilling the lessons learned from the former and transferring this accrued knowledge 
to the latter in an timely and effective manner. 
 
2. Tell us a little bit about your leadership role and how it is changing as a result of the 
pandemic?  
The pandemic has affected directly a number of aspects of work. On the academic side 
I am a lead editor for the COVID-19 special topic and related publications through the 
Frontiers publishing house,1 including fifteen participating journals, such as Frontiers 
in Medicine, Frontiers in Public Health, Frontiers in Health Communication, and more. 
That includes quite a lot of manuscripts (in the high hundreds) that have to be processed 
through the standard peer-review process, and also involves identifying the ones that 
actually need to be out there. They need to be fast-tracked and moving very quickly 
because they're of high clinical impact. On the clinical side, we have supported a 
number of global pathology initiatives, such as the COVID Digital Pathology 
Repository (COVID-DPR) led by the National Institutes of Health, USA.2 
 
 
At the International Agency for Research on Cancer, World Health Organization, I am 
Head of Laboratory Services and Biobanking. Part of my role is to lead a network, 
called BCNet, of 34 laboratories in 22 low- and middle-income countries.3 These 
laboratories are established institutional facilities actively involved in biomedical 
research. Over the last two or three months almost all of them had to shut down normal 
operations, pivot their focus and re-open in preparation for the outbreak, most of them 
as centralised laboratories for the diagnostic testing of covid-19 patients, in their 
respective geographical regions. There was a lot of support needed, and that's why I 
said earlier the information flow was critical, because our colleagues needed steady 
access to accurate information. How should these laboratories now prepare for this 
pandemic? Their situation is very different to Europe. To mention one such difference, 
they are in resource-restricted settings. They obviously need to have the highest clinical 
impact, but they don't have the same capacities in terms of staff, in terms of logistics or 
laboratory supplies, to be as reactive as Europe has been, or the USA.  
In that sense the pandemic really changed our way of working. Normally we would 
receive at least twice weekly different types of shipments of samples collected from 
research participants and patients from across the world as part of international research 
projects- to be tested immediately or kept for future testing. During the outbreak the 
borders are closed, and we are not receiving any samples because they might be 
potentially infectious and that's absolutely fine. We continue to fulfil our role by 
remaining faithful to our principles and by supporting our colleagues in the different 
settings, because often relevant information would come to us first. 
 
3. What events in your past experience are most informing your leadership in this 
pandemic? 
I've been fortunate to work both in hospital and academic settings in the past, in high- 
and low-income countries. In terms of leadership there is an expression I really like by 
F. Scott Fitzgerald, “the test of a first-rate intelligence is the ability to hold two opposed 
ideas in mind at the same time and still retain the ability to function”.4 That is absolutely 
true in this pandemic, where a lot of information can surface very quickly, all at the 
same time, and yet not always congruent. How you bring all this data together so that 
it makes sense is a true mark of leadership. My past work experience in very diverse 
settings has proven critical in that respect. 
 
4. What are you finding the biggest challenges? 
The biggest challenge at the moment is to maintain the spirit of international 
collaboration. One of the decisions taken early on in the course of the pandemic- and 
that was absolutely a correct decision- was to close down borders and impose controls 
on the amount of traveling taking place. However, this can also be perceived as a 
message of limiting international collaborations, because colleagues now have to focus 
urgently on a particular region, delineated by closed borders and/or restricted 
population movement(s). I think the greatest challenge is how to maintain this 
international collaborative spirit, such as sharing experiences and, when needed data. 
We have seen that when it works well, it works really well with great impact. My take 
on this is that the perception of borders is not always physical. It certainly is a physical 
presence, but at times it can also be reflected in behaviours. So maintaining physical 
borders while enhancing the spirit of international collaboration at the same time, 
remains a big challenge. 
 
5. Any particular surprises? 
I think the surprise (and relief) was the way that the public reacted and accepted the 
necessary actions. It helped that medical knowledge was translated by the appropriate 
experts into arguments that everybody can understand and appreciate, making this an 
inclusive decision-making process. 
 
6. Are you seeing any behaviours from colleagues that encourage or inspire you? 
It is amazing to see how many people stand up when they're called, and willing to offer 
their services well beyond the call of duty. This was not just a rare, one-off occurrence 
in one location or in one particular situation. This has been mirrored across many 
places, by many colleagues globally time and again. For example the recently retired 
healthcare professionals who came back to NHS service during this difficult period. 
This mobilised spirit is a very positive outcome of the whole situation. In a lot of cases 
we rediscovered who we really are and what we have to do. 
 
7. How are you maintaining kindness and compassion?  
I listen carefully. A lot of times people actually want to be to be heard, and they really 
appreciate that they're listened to. That talks to the compassion side. The kindness on 
the other hand can be challenging as sometimes from a leadership perspective, you just 
have to take the decision and that might be perceived as unkind. As my mother says, 
you have to keep demonstrating kindness by your actions. You just follow it through. 
 
 
8. Are there any readings that you find helpful for inspiration and support that you 
would recommend to others? 
Oh, yes, absolutely! I would I would definitely recommend a book called ‘The Ghost 
Map’ by Steven Johnson.5 It's about a cholera outbreak in London of Victorian times, 
in the 1850s. It's the story of how the physician had to work together with the reverend 
who is the community leader to try and crack the problem of how to stop cholera from 
spreading in the community. It really talks to what's happening now. We can provide 
all the medical and clinical information, but unless we work together with community 
leaders in all the different locations, it's not going to work- or at least it's not going to 
work as we anticipate. I think this is a really nice book…  and it's got a happy ending. 
They sorted it out.  
 
9. What are you looking for from your leaders? 
I'm looking forward to a lot of strengthened collaborations at the end of this. We've had 
a number of difficult situations that we had to deal with together. I think we've dealt 
with them as effectively as possible. 
You see leaders in a completely different light under duress. In some cases, this has 
been really eye-opening. You understand that actually there is a lot more to an 
individual than originally you might have thought, and it's perhaps time to take a step 
further and try to work with them in the longer-term once this pandemic is over.  
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